US begins airport screenings as SARS-linked virus kills 2 in China

The US will begin screening passengers Friday arriving from a Chinese city at the heart of a mysterious SARS-linked virus, officials said, after an outbreak that has stricken dozens claimed a second life. Three confirmed cases meanwhile have now been reported outside China—two in Thailand and one in Japan—even as health authorities around the world sought to assure the public […]

Continue reading »

As heat strikes, here’s one way to help fight disease-carrying and nuisance mosquitoes

Mosquito-borne disease is a concern for health authorities around Australia. Each year, thousands fall ill to Ross River virus disease caused by mosquito bites. Tracking mosquito populations can help us respond to these threats, and new research suggests citizen scientists may be the key to doing this more effectively. Health authorities coordinate the surveillance of mosquitoes and their pathogens. These […]

Continue reading »

New cancer treatment not as toxic as others

A QIMR Berghofer study has identified how a newly approved blood cancer drug works and found the treatment is better than other drugs at targeting cancer stem cells while causing minimal damage to healthy cells. The long-acting form of the drug Interferon alpha was approved for use in Australia in mid-2018 to treat patients with a type of blood cancer, […]

Continue reading »

Eva Mendes' Kids Dressed as Dorothy Again for Halloween: 'I'm Another Witch'

Happy Halloween! Eva Mendes dressed up with her daughters — in the same outfits they wear every year. “My kid did this,” the actress, 45, captioned her Wednesday, October 30, Instagram Story. “Another Halloween. Another Dorothy. And I’m another witch.” In the social media upload, the Hitch star started into the camera with green makeup covering her face. She wore […]

Continue reading »

Mavyret approved as 8-week treatment for hep C, compensated cirrhosis

(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through 6 and compensated cirrhosis, the U.S. Food and Drug Administration announced last week. Mavyret is the first eight-week treatment approved for any treatment-naive HCV patients, regardless of cirrhosis status or […]

Continue reading »

Persistent headache or back pain ‘twice as likely’ in the presence of the other

People with persistent back pain or persistent headaches are twice as likely to suffer from both disorders, a new study from the University of Warwick has revealed. The results, published in the Journal of Headache and Pain, suggest an association between the two types of pain that could point to a shared treatment for both. The researchers from Warwick Medical […]

Continue reading »
1 2 3 6